FDA issued a Warning Letter to Nostrum Laboratories Inc on 4/27/2009 for a previous inspection.
483 Nostrum Labs Dec 2009

483 Nostrum Labs Dec 2009

Aref El-Demerdash FDA, Warren Lopicka FDA, Matthew Sleeter FDA, Patrick Wisor FDA$119.00 - Available Now

FDA investigators audited the Nostrum Labs - Kansas City, MO, United States facility and issued inspectional observations (via FDA 483) on 01 Dec 2009.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Dec 2009
  • Location: Kansas City, United States
  • FEI: 1930436
Add To Cart